Thursday, Jul 9 2020 | Time 17:46 Hrs(IST)
image
  • Cong misleading farmers on Ordinances on farming : Chhina
  • SKIMS conducts first ever Convalescent Plasma Therapy on COVID patients in J&K
  • nCoV: UP reports 1,248 fresh cases in 24 hrs, tally at 32,362
  • Nagaland COVID-19 cases rise to 660
  • One BSF jawan, two returnees tests positive in Meghalaya
  • Five youth killed in road mishap in Bhatinda
  • Wanted criminal held post-encounter in UP's Badaun
  • NZ Cricket denies reports about offer to host IPL 2020
  • US Supreme Court to rule on revealing Trump tax returns
  • 149 more COVID-19 cases, 7 deaths in Rajasthan
  • SC unhappy over handling of migrant crisis by Maharashtra
  • Sensex regains 408 68 pts
  • Bikru bloodbath mastermind Vikas Dubey nabbed in MP town
  • 4 women die due to COVID-19, death toll mounts to 153 in J&K
India


Guidelines for evaluation of Nanopharmaceuticals in India released

Guidelines for evaluation of Nanopharmaceuticals in India released

New Delhi, Oct 24 (UNI) Union Minister for Science and Technology Dr Harsh Vardhan on Thursday said that “Guidelines for Evaluation of Nanopharmaceuticals in India” is one of the most important steps for delineating quality, safety and efficacy assessment of the novel nano-formulations.

Releasing the Guidelines for Evaluation of Nanopharmaceuticals in India at an event he said that these guidelines are intended to provide transparent, consistent and predictable regulatory pathways for nanopharmaceuticals in India.



“Nanocarrier based targeted drug delivery is an emerging field with introduction of nanopharmaceuticals in the market. These nanoformulations have higher efficacy, lower toxicity and are safer than the conventional drugs”, the Minister further said.

Indian researchers would be facilitated to undertake research in line with the regulatory guidelines and is expected that the industry would be keen to participate from the beginning of the research pipeline towards product development and commercialisation and private investments would also be attracted since these guidelines would strengthen the regulatory system, he added.

The guidelines apply to the nanopharmaceuticals in the form of finished formulation as well as Active Pharmaceutical Ingredient (API) of a new molecule or an already approved molecule with altered nanoscale dimensions, properties or phenomenon associated with the application of nanotechnology intended to be used for treatment, in vivo diagnosis, mitigation, cure or prevention of diseases and disorders in humans.

The guidelines would facilitate translational research in line with the regulatory requirements and will also facilitate the decision making by regulator during clearances to newer products based on nanotechnology and similarly to researchers to get clearance for their products to launch in market. End users will also be benefited by the quality assured anticipated products in the market in accordance to the guidelines.

This document will give impetus to initiate activities for developing safety guidelines for other domains like agri-inputs and agri-products, cosmetics, implantable devices, through interventions of nanotechnology.

The guidelines will pave the way for significant benefits through such cutting edge technology and contribute to the mission on “Affordable Health Care for All”.

The Guidelines are developed by Department of Biotechnology (DBT), Ministry of Science and Technology, Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare and is an outcome of all concerned Inter-Ministerial efforts coordinated by DBT, the official release said.

UNI AKS SHK2116

More News

Alliance Air recommencing flights between Delhi, Kullu

09 Jul 2020 | 4:26 PM

New Delhi, Jul 9 (UNI) Alliance Air will be re-commencing its flight operations between Delhi to Kullu, Himachal Pradesh from July 16.

see more..
Is govt diluting India’s claim over Galwan Valley, asks Congress

Is govt diluting India’s claim over Galwan Valley, asks Congress

09 Jul 2020 | 4:22 PM

New Delhi, Jul 9 (UNI) Continuing its attack on Prime Minister Narendra Modi and the NDA government for their failure to prevent incursion on Indian territory by China, the Congress on Thursday asked whether the government was diluting India's claim on the Galwan Valley by creating a buffer zone on it's own territory.

see more..
Delhi HC asks DU on how it plans to conduct final year exams

Delhi HC asks DU on how it plans to conduct final year exams

09 Jul 2020 | 3:53 PM

New Delhi, Jul 9 (UNI) The Delhi High Court on Thursday directed the Delhi University (DU) to furnish an affidavit detailing the schedule of final year undergraduate examinations.

see more..
Shah greets ABVP members on its 72nd Foundation Day

Shah greets ABVP members on its 72nd Foundation Day

09 Jul 2020 | 3:29 PM

New Delhi, Jul 9 (UNI) Union Home Minister Amit Shah on Thursday greeted the members of student wing Akhil Bharatiya Vidyarthi Parishad (ABVP)on its 72nd Foundation Day.

see more..
India has lowest cases and deaths/million population: Dr Harsh Vardhan tells GoM

India has lowest cases and deaths/million population: Dr Harsh Vardhan tells GoM

09 Jul 2020 | 3:09 PM

New Delhi, Jul 9 (UNI) Maharashtra, Tamil Nadu, West Bengal and three other states account for 86 per cent of total Coronavirus deaths, while 32 districts account for 80 per cent of the deaths.

see more..
image